Literature DB >> 21248655

Outcome of urinary tract infections caused by extended spectrum β-lactamase-producing Enterobacteriaceae in children.

Athanasios Tratselas1, Elias Iosifidis, Maria Ioannidou, Stamatis Saoulidis, Konstantinos Kollios, Charalampos Antachopoulos, Danai Sofianou, Emmanuel J Roilides.   

Abstract

The outcome of patients with urinary tract infections caused by extended spectrum β-lactamases (ESBL)-producing bacteria (cases) was compared with that of matched controls with urinary tract infections caused by non-extended spectrum β-lactamases-producing isolates. Significantly, more case patients received inappropriate empiric therapy than controls. Nevertheless, clinical and microbiologic outcomes as well as formation of renal scars did not differ between the 2 groups.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21248655     DOI： 10.1097/INF.0b013e31820d7ec4

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  14 in total

Review 1.  Diagnosis of Urinary Tract Infections in Children.

Authors:  Christopher D Doern; Susan E Richardson
Journal:  J Clin Microbiol       Date:  2016-04-06       Impact factor: 5.948

Review 2.  Antibiotic Resistance in Pediatric Urinary Tract Infections.

Authors:  Jeremy S Stultz; Christopher D Doern; Emily Godbout
Journal:  Curr Infect Dis Rep       Date:  2016-12       Impact factor: 3.725

3.  Spread of CTX-M-15 extended-spectrum β-lactamase-producing Escherichia coli isolates through household contact and plasmid transfer.

Authors:  Yasuko Kojima; Sohei Harada; Kotaro Aoki; Yoshikazu Ishii; Tomoka Sawa; Kei Hasegawa; Tsutomu Saji; Keizo Yamaguchi; Kazuhiro Tateda
Journal:  J Clin Microbiol       Date:  2014-02-19       Impact factor: 5.948

4.  Urinary tract infections in infants and children: Diagnosis and management.

Authors:  Joan L Robinson; Jane C Finlay; Mia Eileen Lang; Robert Bortolussi
Journal:  Paediatr Child Health       Date:  2014-06       Impact factor: 2.253

Review 5.  Update on recent guidelines for the management of urinary tract infections in children: the shifting paradigm.

Authors:  Elijah Paintsil
Journal:  Curr Opin Pediatr       Date:  2013-02       Impact factor: 2.856

6.  Effect of ceftriaxone on the outcome of murine pyelonephritis caused by extended-spectrum-β-lactamase-producing Escherichia coli.

Authors:  A Tratselas; M Simitsopoulou; A Giannakopoulou; I Dori; S Saoulidis; K Kollios; P Papaioannidou; S Pournaras; E Roilides
Journal:  Antimicrob Agents Chemother       Date:  2014-09-15       Impact factor: 5.191

7.  Clinical patterns, epidemiology and risk factors of community-acquired urinary tract infection caused by extended-spectrum beta-lactamase producers: a prospective hospital case-control study.

Authors:  Basima A Almomani; Wail A Hayajneh; Abeer M Ayoub; Mera A Ababneh; Miral A Al Momani
Journal:  Infection       Date:  2018-05-10       Impact factor: 3.553

8.  Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.

Authors:  Seung Beom Han; Sung Chul Lee; Soo Young Lee; Dae Chul Jeong; Jin Han Kang
Journal:  BMC Infect Dis       Date:  2015-10-13       Impact factor: 3.090

9.  Third-generation cephalosporin-resistant urinary tract infections in children presenting to the paediatric emergency department.

Authors:  Kristopher T Kang; Karen Ng; Jennifer Kendrick; Peter Tilley; Joseph Ting; Shahrad Rassekh; Srinivas Murthy; Ashley Roberts
Journal:  Paediatr Child Health       Date:  2019-02-05       Impact factor: 2.253

10.  Validation of Cefazolin as Initial Antibiotic for First Upper Urinary Tract Infection in Children.

Authors:  Yoshifusa Abe; Hitomi Wakabayashi; Yasuha Ogawa; Ayano Machida; Mio Endo; Tetsuro Tamai; Shunsuke Sakurai; Satoshi Hibino; Takeshi Mikawa; Yoshitaka Watanabe; Kazuhisa Ugajin; Kunihiko Fukuchi; Kazuo Itabashi
Journal:  Glob Pediatr Health       Date:  2016-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.